Heart failure & cardiomyopathies

Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial

JAMA CardiolPublished Post hoc analysis of the REDUCE LAP-HF II randomised trial

Authors' conclusion

In this post hoc analysis of the REDUCE LAP-HF II trial, over 2 years of follow-up, atrial shunting led to reverse remodeling of left-sided chambers and increases in volume of right-sided chambers consistent with the shunt flow but no change in RV systolic function compared with sham.

Study context

Population
Heart failure with preserved ejection fraction (HFpEF)/HF with mildly reduced EF, with evaluable echocardiographymodified ITT
Participants
621 participants
Comparison
Atrial shunt device vs sham control
  • Shuntn = 309
  • Sham controln = 312reference
Primary endpoint
Changes in echocardiographic measures from baseline
Follow-up
1, 6, 12, and 24 months after index procedure
Methodological detailssham-controlled, 89 international centres, modified ITT, Data analyzed April 2023 to January 2024
  • Sham-controlled
  • 89 international centres
  • Modified ITT
  • Data analyzed April 2023 to January 2024

Primary result

As reported in the abstract

Echocardiographic changes, overall population · through 24 months
Left ventricular (LV) end-diastolic volume
mean difference −5.65 mL; P < 0.001
Left atrial (LA) minimal volume
mean difference −2.8 mL; P = 0.01
LV systolic tissue Doppler velocity
mean difference 0.69 cm/s; P < 0.001
LA emptying fraction
mean difference 1.88 percentage units; P = 0.02
Right ventricular (RV) volume
mean difference 9.58 mL; P < 0.001
Right atrial (RA) volume
mean difference 9.71 mL; P < 0.001

Further findings

Shunt patency (shunt patients with evaluable echocardiograms) · through 24 months
98% · 212
  • Shunt patency (shunt patients with evaluable echocardiograms): 212 of 217

Echocardiographic changes, responders vs nonresponders within shunt (subgroup)

RV end-diastolic volume: mean difference 5.71 mL vs 15.18 mL
interaction P =.01
RV end-systolic volume: mean difference 1.58 mL vs 7.89 mL
interaction P =.002
RV/LV ratio: mean difference 0.07 vs 0.20
interaction P <.001
Transmitral A wave velocity: mean difference 5.08 cm/s vs −1.97 cm/s
interaction P =.02
  • Responders: no latent pulmonary vascular disease and no cardiac rhythm management device
  • Post hoc

Original publication

Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial. JAMA Cardiol. Published 1 June 2024. doi:10.1001/jamacardio.2024.0520

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.